Search

Highlights of Past EHA (HOPE ) Asia 2021 - report

In the first weekend of September (September 3-4), EHA opened the virtual platform for HOPE Asia 2021.

Read more

Publications

Guideline Under Revision: Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia
Achille Iolascon, Immacolata Andolfo, Roberta Russo, Mayka Sanchez, Fabiana Busti, Dorine Swinkels, Patricia Aguilar Martinez, Rayan Bou-Fakhredin, Martina U.

Read more

EHA Research Grants

The call for applications will close on October 15, 2024, at 15:00 (CEST).

Read more

EHA, AHA and GBMTA Successfully Conclude the First Joint Virtual Mini Hematology Tutorial

 EHA-AHA-GBMTA Mini Hematology Tutorial

November 10-11, 2021

Meeting chairs:

Prof G Gaidano (European Hematology Association)
Prof YK Hakobyan (Armenian Hematology Association)
Dr T Kvatchadze (Georgian Association For Blood and Bone Marrow Transplantation)
EHA, the Armenian Hematology Association (AHA) and for the first time with the Georgian…

Read more

HARMONY: Big data for better and faster treatment

HARMONY Alliance: A European Network of Excellence for Big Data in Hematology - Enabling Better and Faster Treatment based on Big Data technologies
Despite data being a key driver for modern evidence-based medicine, we have been struggling with the same challenge for…

Read more

European Hematology Curriculum

Harmonization of hematology knowledge is part of EHA’s mission. The first step in harmonizing hematology training is to stipulate the required fields of knowledge, each with its recommended level of competence.

Read more

EHA-PTHiT Hematology Tutorial on Novel Treatment Approaches in Hematologic Malignancies

EHA in collaboration with the Polish Society for Hematology and Transfusion (PTHiT) have decided to postpone this highly anticipated Hematology Tutorial to a future date, to be announced.

Read more

Without access to treatment, can we truly innovate in rare diseases?

Interview with Giampaolo Merlini

There have been many developments on rare diseases since the EU Orphan Medicinal Products Regulation came into force in 2000. As the European Commission is evaluating its effectiveness, EHA discussed with Prof.

Read more